Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update
The Company plans to hold a conference call in early December to provide a comprehensive RP1 skin cancer program update including:
Chris Brinzey Bristol Myers Squibb Philip Astley Sparke Arleen Goldenberg Program Highlights Milestones Society For Immunotherapy Of Cancer
Source: eagletribune.com